Treatment of refractory chronic GVHD with rituximab: a GITMO study.

MLA

Zaja, F., et al. “Treatment of Refractory Chronic GVHD with Rituximab: A GITMO Study.” Bone Marrow Transplantation, vol. 40, no. 3, Aug. 2007, pp. 273–77. EBSCOhost, https://doi.org/10.1038/sj.bmt.1705725.

APA

Zaja, F., Bacigalupo, A., Patriarca, F., Stanzani, M., Van Lint, M. T., Filì, C., Scimè, R., Milone, G., Falda, M., Vener, C., Laszlo, D., Alessandrino, P. E., Narni, F., Sica, S., Olivieri, A., Sperotto, A., Bosi, A., Bonifazi, F., & Fanin, R. (2007). Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplantation, 40(3), 273–277. https://doi.org/10.1038/sj.bmt.1705725

Chicago

Zaja, F, A Bacigalupo, F Patriarca, M Stanzani, M T Van Lint, C Filì, R Scimè, et al. 2007. “Treatment of Refractory Chronic GVHD with Rituximab: A GITMO Study.” Bone Marrow Transplantation 40 (3): 273–77. doi:10.1038/sj.bmt.1705725.